Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat

Diana Amantea, Rossella Russo, Micaela Gliozzi, Vincenza Fratto, Laura Berliocchi, G. Bagetta, G. Bernardi, M. Tiziana Corasaniti

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Abnormal expression of matrix metalloproteinases (MMPs) has been implicated in the pathophysiology of neuroinflammatory processes that accompany most central nervous system disease. In particular, early upregulation of the gelatinases MMP-2 and MMP-9 has been shown to contribute to disruption of the blood-brain barrier and to death of neurons in ischemic stroke. In situ zymography reveals a significant increase in gelatinolytic MMPs activity in the ischemic brain hemisphere after 2-h middle cerebral artery occlusion (MCAo) followed by 2-h reperfusion in rat. Accordingly, gel zymography demonstrates that expression and activity of MMP-2 and MMP-9 are enhanced in cortex and striatum ipsilateral to the ischemic insult. The latter effect appears to be instrumental for development of delayed brain damage since administration of a broad spectrum, highly specific MMPs inhibitor, GM6001, but not by its negative control, results in a significant (50%) reduction in ischemic brain volume. Increased gelatinase activity in the ischemic cortex coincides with elevation (166% vs sham) of mature interleukin-1β (IL-1β) after 2-h reperfusion and this does not appear to implicate a caspase-1-dependent processing of pro(31 kDa)-IL-1β to yield mature (17 kDa) IL-1β. More importantly, when administered at a neuroprotective dose GM6001 abolishes the early IL-1β increase in the ischemic cortex and reduces the cleavage of the cytokine proform supporting the deduction that MMPs may initiate IL-1β processing. In conclusion, development of tissue damage that follows transient ischemia implicates a crucial interplay between MMPs and mediators of neuroinflammation (e.g., IL-1β), and this further underscores the therapeutic potential of MMPs inhibitors in the treatment of stroke.

Original languageEnglish
Pages (from-to)149-169
Number of pages21
JournalInternational Review of Neurobiology
Volume82
DOIs
Publication statusPublished - 2007

Fingerprint

Brain Ischemia
Matrix Metalloproteinases
Interleukin-1
Reperfusion
Up-Regulation
Gelatinases
Matrix Metalloproteinase Inhibitors
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Brain
Stroke
Caspase 1
Middle Cerebral Artery Infarction
Central Nervous System Diseases
Blood-Brain Barrier
Ischemia
Gels
Cytokines
Neurons

ASJC Scopus subject areas

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology
  • Physiology

Cite this

Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat. / Amantea, Diana; Russo, Rossella; Gliozzi, Micaela; Fratto, Vincenza; Berliocchi, Laura; Bagetta, G.; Bernardi, G.; Corasaniti, M. Tiziana.

In: International Review of Neurobiology, Vol. 82, 2007, p. 149-169.

Research output: Contribution to journalArticle

Amantea, Diana ; Russo, Rossella ; Gliozzi, Micaela ; Fratto, Vincenza ; Berliocchi, Laura ; Bagetta, G. ; Bernardi, G. ; Corasaniti, M. Tiziana. / Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat. In: International Review of Neurobiology. 2007 ; Vol. 82. pp. 149-169.
@article{79dc006938b74e07ba77d6b6d369f3d8,
title = "Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat",
abstract = "Abnormal expression of matrix metalloproteinases (MMPs) has been implicated in the pathophysiology of neuroinflammatory processes that accompany most central nervous system disease. In particular, early upregulation of the gelatinases MMP-2 and MMP-9 has been shown to contribute to disruption of the blood-brain barrier and to death of neurons in ischemic stroke. In situ zymography reveals a significant increase in gelatinolytic MMPs activity in the ischemic brain hemisphere after 2-h middle cerebral artery occlusion (MCAo) followed by 2-h reperfusion in rat. Accordingly, gel zymography demonstrates that expression and activity of MMP-2 and MMP-9 are enhanced in cortex and striatum ipsilateral to the ischemic insult. The latter effect appears to be instrumental for development of delayed brain damage since administration of a broad spectrum, highly specific MMPs inhibitor, GM6001, but not by its negative control, results in a significant (50{\%}) reduction in ischemic brain volume. Increased gelatinase activity in the ischemic cortex coincides with elevation (166{\%} vs sham) of mature interleukin-1β (IL-1β) after 2-h reperfusion and this does not appear to implicate a caspase-1-dependent processing of pro(31 kDa)-IL-1β to yield mature (17 kDa) IL-1β. More importantly, when administered at a neuroprotective dose GM6001 abolishes the early IL-1β increase in the ischemic cortex and reduces the cleavage of the cytokine proform supporting the deduction that MMPs may initiate IL-1β processing. In conclusion, development of tissue damage that follows transient ischemia implicates a crucial interplay between MMPs and mediators of neuroinflammation (e.g., IL-1β), and this further underscores the therapeutic potential of MMPs inhibitors in the treatment of stroke.",
author = "Diana Amantea and Rossella Russo and Micaela Gliozzi and Vincenza Fratto and Laura Berliocchi and G. Bagetta and G. Bernardi and Corasaniti, {M. Tiziana}",
year = "2007",
doi = "10.1016/S0074-7742(07)82008-3",
language = "English",
volume = "82",
pages = "149--169",
journal = "International Review of Neurobiology",
issn = "0074-7742",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat

AU - Amantea, Diana

AU - Russo, Rossella

AU - Gliozzi, Micaela

AU - Fratto, Vincenza

AU - Berliocchi, Laura

AU - Bagetta, G.

AU - Bernardi, G.

AU - Corasaniti, M. Tiziana

PY - 2007

Y1 - 2007

N2 - Abnormal expression of matrix metalloproteinases (MMPs) has been implicated in the pathophysiology of neuroinflammatory processes that accompany most central nervous system disease. In particular, early upregulation of the gelatinases MMP-2 and MMP-9 has been shown to contribute to disruption of the blood-brain barrier and to death of neurons in ischemic stroke. In situ zymography reveals a significant increase in gelatinolytic MMPs activity in the ischemic brain hemisphere after 2-h middle cerebral artery occlusion (MCAo) followed by 2-h reperfusion in rat. Accordingly, gel zymography demonstrates that expression and activity of MMP-2 and MMP-9 are enhanced in cortex and striatum ipsilateral to the ischemic insult. The latter effect appears to be instrumental for development of delayed brain damage since administration of a broad spectrum, highly specific MMPs inhibitor, GM6001, but not by its negative control, results in a significant (50%) reduction in ischemic brain volume. Increased gelatinase activity in the ischemic cortex coincides with elevation (166% vs sham) of mature interleukin-1β (IL-1β) after 2-h reperfusion and this does not appear to implicate a caspase-1-dependent processing of pro(31 kDa)-IL-1β to yield mature (17 kDa) IL-1β. More importantly, when administered at a neuroprotective dose GM6001 abolishes the early IL-1β increase in the ischemic cortex and reduces the cleavage of the cytokine proform supporting the deduction that MMPs may initiate IL-1β processing. In conclusion, development of tissue damage that follows transient ischemia implicates a crucial interplay between MMPs and mediators of neuroinflammation (e.g., IL-1β), and this further underscores the therapeutic potential of MMPs inhibitors in the treatment of stroke.

AB - Abnormal expression of matrix metalloproteinases (MMPs) has been implicated in the pathophysiology of neuroinflammatory processes that accompany most central nervous system disease. In particular, early upregulation of the gelatinases MMP-2 and MMP-9 has been shown to contribute to disruption of the blood-brain barrier and to death of neurons in ischemic stroke. In situ zymography reveals a significant increase in gelatinolytic MMPs activity in the ischemic brain hemisphere after 2-h middle cerebral artery occlusion (MCAo) followed by 2-h reperfusion in rat. Accordingly, gel zymography demonstrates that expression and activity of MMP-2 and MMP-9 are enhanced in cortex and striatum ipsilateral to the ischemic insult. The latter effect appears to be instrumental for development of delayed brain damage since administration of a broad spectrum, highly specific MMPs inhibitor, GM6001, but not by its negative control, results in a significant (50%) reduction in ischemic brain volume. Increased gelatinase activity in the ischemic cortex coincides with elevation (166% vs sham) of mature interleukin-1β (IL-1β) after 2-h reperfusion and this does not appear to implicate a caspase-1-dependent processing of pro(31 kDa)-IL-1β to yield mature (17 kDa) IL-1β. More importantly, when administered at a neuroprotective dose GM6001 abolishes the early IL-1β increase in the ischemic cortex and reduces the cleavage of the cytokine proform supporting the deduction that MMPs may initiate IL-1β processing. In conclusion, development of tissue damage that follows transient ischemia implicates a crucial interplay between MMPs and mediators of neuroinflammation (e.g., IL-1β), and this further underscores the therapeutic potential of MMPs inhibitors in the treatment of stroke.

UR - http://www.scopus.com/inward/record.url?scp=34547379395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547379395&partnerID=8YFLogxK

U2 - 10.1016/S0074-7742(07)82008-3

DO - 10.1016/S0074-7742(07)82008-3

M3 - Article

C2 - 17678960

AN - SCOPUS:34547379395

VL - 82

SP - 149

EP - 169

JO - International Review of Neurobiology

JF - International Review of Neurobiology

SN - 0074-7742

ER -